IL10 and familial pancreatic carcinoma: Their functions are active, and they secrete large amounts of interleukin-10 (IL-10), TGF-β, IDO and other immunosuppressive factors to form an immunosuppressive TME in pancreatic cancer, which inhibits the immune response and causes immune escape to alter the effect of immunotherapy18.